Device Podiatry

Stimrouter Implantable Kit

Payments companies reported to CMS as associated with Stimrouter Implantable Kit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$493Kassociated payments (2023-2025)
582clinicians with associated payments
1company reporting

By year

2023 $281K
2024 $87K
2025 $125K

Payments reported as associated with Stimrouter Implantable Kit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pain Medicine (Anesthesiology) $108K
Anesthesiology $87K
Orthopaedic Surgery $86K
Pain Medicine (Physical Medicine & Rehabilitation) $76K
Interventional Pain Medicine $35K
Foot & Ankle Surgery $23K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Stimrouter Implantable Kit

These are the largest totals companies reported as associated with Stimrouter Implantable Kit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Spinner New York, NY Pain Medicine (Physical Medicine & Rehabilitation) $71,385.56
Vinod Dasa Kenner, LA Orthopaedic Surgery $70,716.79
Einar Ottestad Stanford, CA Pain Medicine (Anesthesiology) $52,083.21
Sam Nia Worcester, MA Anesthesiology $44,289.04
Alexandra Adler Lowell, MA Pain Medicine (Anesthesiology) $22,319.81
Mansoor Aman De Pere, WI Anesthesiology $15,795.43
Reuel Measom Albuquerque, NM Interventional Pain Medicine $14,872.57
Ramana Naidu Larkspur, CA Pain Medicine (Anesthesiology) $13,702.24
Meredith Warner Baton Rouge, LA Foot and Ankle Surgery $12,686.27
Stephen Barrett Marietta, GA Podiatrist $10,635.52

Prescribed Stimrouter Implantable Kit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.